246 participants
Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-05-30
- Start Date:
- 2014-10-31
- Completion:
- 2018-04-30
Conditions
- Prostatic Neoplasms
Interventions
- DRUG
No Results Yet